Lakewood-Amedex Biotherapeutics Inc.(LABT)
$0.36-0.04 (-9.11%)
LABT
Lakewood-Amedex Biotherapeutics Inc. stock forecast
$0.36
At close:-0.04 (-9.11%)
Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock Forecast & Price Target
29 Followers
LABT Analyst Ratings
Moderate Buy
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Lakewood-Amedex Biotherapeutics Inc. in the past 3 months
LABT Stock 12 Month Forecast
Average Price Target
$3.00▲(735.65% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Lakewood-Amedex Biotherapeutics Inc. in the last 3 months. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 735.65% change from the last price of $0.36.
Past 12 Months12 Month ForecastJan2026Oct2026
High$3.00
Average$3.00
Low$3.00
Highest Price TargetHighest$3.00Average Price Target$3.00Lowest Price TargetLowest$3.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Matthew Keller | H.C. Wainwright | $3 | buy | 735.65%Upside | Initiated | 10/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Matthew KellerH.C. Wainwright | BuyInitiated$3 | 10/28/26 | 735.65%Upside |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Lakewood-Amedex Biotherapeutics Inc.
3 Months
Success Rate0/1 ratings generated profit
0%
Average Return
-31.50%
Copying Matthew Keller's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -31.50% per trade.
1 Year
Success Rate0/1 ratings generated profit
0%
Average Return
-31.50%
Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.50% per trade.
2 Years
Success Rate0/1 ratings generated profit
0%
Average Return
-31.50%
Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -31.50% per trade.
LABT Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 1 | 1 |
In the current month, LABT has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LABT average Analyst price target in the past 3 months is 3.00.
LABT Financial Forecast
LABT Stock Forecast FAQ
What is LABT’s average 12-month price target, according to analysts?
Based on analyst ratings, Lakewood-Amedex Biotherapeutics Inc.’s 12-month average price target is $3.00.
What is LABT’s upside potential, based on the analysts’ average price target?
Lakewood-Amedex Biotherapeutics Inc. has 735.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LABT a Buy, Sell or Hold?
Lakewood-Amedex Biotherapeutics Inc. has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lakewood-Amedex Biotherapeutics Inc.’s price target?
The average price target for Lakewood-Amedex Biotherapeutics Inc. is $3.00. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $3.00, the lowest forecast is $3.00. The average price target represents a 735.65% increase from the current price of $0.359.
What do analysts say about Lakewood-Amedex Biotherapeutics Inc.?
Lakewood-Amedex Biotherapeutics Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of LABT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
